These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Neurochemical development of the degenerating rat retina. Fletcher EL; Kalloniatis M J Comp Neurol; 1997 Nov; 388(1):1-22. PubMed ID: 9364235 [TBL] [Abstract][Full Text] [Related]
46. Cerebrospinal fluid hypoxanthine, xanthine and uric acid levels may reflect glutamate-mediated excitotoxicity in different neurological diseases. Stover JF; Lowitzsch K; Kempski OS Neurosci Lett; 1997 Nov; 238(1-2):25-8. PubMed ID: 9464646 [TBL] [Abstract][Full Text] [Related]
47. [Glutamate neurotransmission and calcium metabolism in cerebral ischaemia and under normal conditions]. Gusev EI; Skvortsova VI Usp Fiziol Nauk; 2002; 33(4):80-93. PubMed ID: 12449809 [TBL] [Abstract][Full Text] [Related]
48. Amino acid neurotransmitters in nucleus tractus solitarius: an in vivo microdialysis study. Sved AF; Curtis JT J Neurochem; 1993 Dec; 61(6):2089-98. PubMed ID: 7902420 [TBL] [Abstract][Full Text] [Related]
49. Dextrorphan inhibits the release of excitatory amino acids during spinal cord ischemia. Rokkas CK; Helfrich LR; Lobner DC; Choi DW; Kouchoukos NT Ann Thorac Surg; 1994 Aug; 58(2):312-9; discussion 319-20. PubMed ID: 7915102 [TBL] [Abstract][Full Text] [Related]
50. Neurological deterioration in acute lacunar infarctions: the role of excitatory and inhibitory neurotransmitters. Serena J; Leira R; Castillo J; Pumar JM; Castellanos M; Dávalos A Stroke; 2001 May; 32(5):1154-61. PubMed ID: 11340225 [TBL] [Abstract][Full Text] [Related]
51. Changes in blood neurotransmitter and steroid levels during evoked vertigo. Dagilas A; Kimiskidis V; Aggelopoulou M; Kapaki E; Fitili C; Libitaki G; Papagiannopoulos S; Kazis D; Kazis A; Aidonis A Otol Neurotol; 2005 May; 26(3):476-80; discussion 480. PubMed ID: 15891652 [TBL] [Abstract][Full Text] [Related]
53. Effect of branched-chain amino acids on glutamate metabolism in amyotrophic lateral sclerosis. Gredal O; Møller SE J Neurol Sci; 1995 Mar; 129(1):40-3. PubMed ID: 7751843 [TBL] [Abstract][Full Text] [Related]
54. Neurotrophic factors in the pathogenesis of Rett syndrome. Riikonen R J Child Neurol; 2003 Oct; 18(10):693-7. PubMed ID: 14649551 [TBL] [Abstract][Full Text] [Related]
55. Increased CSF glutamate following injection of ALS immunoglobulins. La Bella V; Goodman JC; Appel SH Neurology; 1997 May; 48(5):1270-2. PubMed ID: 9153455 [TBL] [Abstract][Full Text] [Related]
56. Excitatory amino acids in the cerebrospinal fluid of asphyxiated infants: relationship to hypoxic-ischemic encephalopathy. Hagberg H; Thornberg E; Blennow M; Kjellmer I; Lagercrantz H; Thiringer K; Hamberger A; Sandberg M Acta Paediatr; 1993 Nov; 82(11):925-9. PubMed ID: 7906573 [TBL] [Abstract][Full Text] [Related]
57. Determination of delta-aminobutyric acid and other amino acids in cerebrospinal fluid of pediatric patients by reversed-phase liquid chromatography. Goldsmith RF; Earl JW; Cunningham AM Clin Chem; 1987 Oct; 33(10):1736-40. PubMed ID: 2889543 [TBL] [Abstract][Full Text] [Related]
58. Relationship of CSF neurotransmitter metabolite levels to disease severity and disability in multiple sclerosis. Markianos M; Koutsis G; Evangelopoulos ME; Mandellos D; Karahalios G; Sfagos C J Neurochem; 2009 Jan; 108(1):158-64. PubMed ID: 19014375 [TBL] [Abstract][Full Text] [Related]
59. Effects of excitatory amino acids, and of their agonists and antagonists on the release of neurotransmitters from the chick retina. Morán J; Pasantes-Morales H J Neurosci Res; 1983; 10(3):261-71. PubMed ID: 6139487 [TBL] [Abstract][Full Text] [Related]
60. Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis. Cawley N; Solanky BS; Muhlert N; Tur C; Edden RA; Wheeler-Kingshott CA; Miller DH; Thompson AJ; Ciccarelli O Brain; 2015 Sep; 138(Pt 9):2584-95. PubMed ID: 26304151 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]